Dr. He is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 E 28th St
Ste 401
Minneapolis, MN 55407Phone+1 612-863-0200Fax+1 612-273-4098
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2015 - 2018- University of MinnesotaResidency, Internal Medicine, 2012 - 2015
Geisel School of Medicine at DartmouthClass of 2012
Certifications & Licensure
MN State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsThe Prevalence of Pretransplant Frailty and Mental Distress in Hematopoietic Cell Transplantation and Association with Clinical Outcomes.Shivjot Singh, Qing Cao, Connor Demorest, Fiona He, Angela Kramer
Transplantation and Cellular Therapy. 2024-09-01 - 1 citationsImmunohistochemistry screening for TP53 mutation in myeloid neoplasms in AZF-fixed bone marrow biopsies.Guang Yang, Sarah Anderson Williams, Fiona He, Yuyu He, Kelsey McIntyre
Pathology. 2024-04-01 - 4 citationsLong-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.Ulrich Jaeger, Constantine S Tam, Peter Borchmann, Joseph P McGuirk, Marianne Johansen
Blood Advances. 2022-08-23
Journal Articles
- Low Day +100 Serum Epidermal Growth Factor Levels Are Associated With Acute Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationHe F, Verneris M, Cooley S, Blazar B, MacMillan M, Newell L , Panoskaltsis-Mortari A, Weisdorf DJ, Holtan S, Bone Marrow Transplant, 11/21/2016
Abstracts/Posters
- Cell Type-Specific Effects of Crizotinib in Human Acute Myeloid Leukemia with TP53 AlterationsFiona He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multip...Fiona He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
